NSCLC Stage IIIC
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy (NCT04676386) | Addario Lung Cancer Medical Institute | 2021-02-01 |
| Phase 2 Study of Dacomitinib in NSCLC (NCT04027647) | National Cancer Centre, Singapore | 2019-09-11 |
| Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (NCT03805841) | Rain Oncology Inc | 2019-03-13 |
Track NSCLC Stage IIIC automatically
Every clearance here is in the API, with alerts when new ones post.